Navis Wealth Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,500
| Closed | -$405K | – | 110 |
|
|
2024
Q4 | $405K | Buy |
4,500
+2,100
| +88% | +$189K | 0.44% | 53 |
|
|
2024
Q3 | $237K | Sell |
2,400
-280
| -10% | -$27.7K | 0.26% | 89 |
|
|
2024
Q2 | $248K | Hold |
2,680
| – | – | 0.29% | 84 |
|
|
2024
Q1 | $254K | Buy |
+2,680
| New | +$254K | 0.31% | 80 |
|
|
2022
Q4 | – | Sell |
-6,612
| Closed | -$524K | – | 95 |
|
|
2022
Q3 | $524K | Hold |
6,612
| – | – | 0.81% | 29 |
|
|
2022
Q2 | $491K | Sell |
6,612
-1,550
| -19% | -$115K | 0.53% | 41 |
|
|
2022
Q1 | $734K | Buy |
8,162
+100
| +1% | +$8.99K | 0.65% | 38 |
|
|
2021
Q4 | $903K | Buy |
8,062
+1,450
| +22% | +$162K | 0.76% | 30 |
|
|
2021
Q3 | $831K | Hold |
6,612
| – | – | 0.58% | 32 |
|
|
2021
Q2 | $895K | Hold |
6,612
| – | – | 0.75% | 29 |
|
|
2021
Q1 | $897K | Buy |
6,612
+2
| +0% | +$271 | 0.69% | 27 |
|
|
2020
Q4 | $931K | Buy |
+6,610
| New | +$931K | 0.84% | 27 |
|